ORYZON GENOMICS SA EO-,05

Share · ES0167733015 · A2ACV2 (XMAD)

Overview

No Price

Closing Price XMAD 09.12.2025: 3,52 EUR

15.12.2025 07:28

Current Prices from ORYZON GENOMICS SA EO-,05

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
Frankfurt	ORN.F	EUR	15.12.2025 07:28	3,03 EUR	-0,08 EUR -2,58 %
Quotrix	OGSAAP15.DUSD	EUR	15.12.2025 06:27	3,16 EUR	0,05 EUR +1,61 %
Düsseldorf	OGSAAP15.DUSB	EUR	11.12.2025 18:31	3,14 EUR	-0,09 EUR -2,79 %
Hamburg	OGSAAP15.HAMB	EUR	11.12.2025 07:10	3,16 EUR	-0,07 EUR -2,17 %
Madrid	ORY.MC	EUR	09.12.2025 08:30	3,52 EUR	0,15 EUR +4,30 %
London	0RDB.L	EUR	09.12.2025 08:12	3,48 EUR	0,10 EUR +2,96 %
UTC	ORYZF	USD	08.12.2025 21:00	3,36 USD	0,00 USD

Share Float & Liquidity

Free Float 76,69 %

Shares Float 60,47 M

Shares Outstanding 78,85 M

Company Profile for ORYZON GENOMICS SA EO-,05 Share

Oryzon Genomics S.A., a clinical phase biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, an LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases. The company was founded in 2000 and is based in Cornellà de Llobregat, Spain.

Get up to date insights from finAgent about ORYZON GENOMICS SA EO-,05

Company Data

Name ORYZON GENOMICS SA EO-,05

Company Oryzon Genomics S.A.

Website https://www.oryzon.com

Primary Exchange

Madrid

WKN A2ACV2

ISIN ES0167733015

Asset Class Share

Sector Healthcare

Industry Medical - Pharmaceuticals

CEO Carlos Manuel Buesa Arjol

Market Capitalization 265 Mio

Country Spain

Currency EUR

Employees 0,0 T

Address Sant Ferran 74, 08940 Cornellà de Llobregat

IPO Date 2016-12-15

Ticker Symbols

Name	Symbol
Over The Counter	ORYZF
Düsseldorf	OGSAAP15.DUSB
Frankfurt	ORN.F
Hamburg	OGSAAP15.HAMB
London	0RDB.L
Madrid	ORY.MC
Quotrix	OGSAAP15.DUSD

More Shares

Investors who hold ORYZON GENOMICS SA EO-,05 also have the following shares in their portfolio:

AMERICAN SHIPPING C10 Share

ANGLIAN WATER SERVICES FINANCING PLC 3.00% CLASS A GREEN BONDS 06/02/31 Bond

APPLIED THERAPEUTICSCS INC Share

Ashapuri Gold Ornament Limited Share

ASML HOLDING Share

BRITISH AMERICAN TOBACCO Share

ESPORTS ENTERTAINMENT GROUP INC Share

MASTERFLEX Share

NINTENDO CO LTD Share

ORCHARD THERAPEUTICSCS PLC - AMERICAN DEPOSITARY SHARES Depository Receipt

PALANTIR TECHNOLOGIESLOGIES INC CLASS A Share

THERMO FISHER SCIENTIFIC INC Share

TIANNENG POWER HD -,1 Share

XIAOMI CORP CL.B Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog